F5 Networks, Inc. (NASDAQ:FFIV) reported net income for the first quarter of $89.1 million or $1.21 per share, compared to $68.0 million or $0.87 per share for the year-ago quarter. Excluding the impact of stock-based compensation and amortization of purchased intangible assets, adjusted net income for the first quarter was $114.2 million or $1.55 per share, compared to $94.8 million or $1.22 per share in the prior year quarter. On Wednesday shares of F5 Networks, Inc. (NASDAQ:FFIV) closed at $125.95. Company’s sales growth for last 5 years was 21.50% and EPS growth for next 5 years is recorded as 16.72%.
On January 14, Shareholder rights law firm Robbins Arroyo LLP is investigating whether certain officers and directors of Arrowhead Research Corporation (NASDAQ:ARWR) breached their fiduciary duties to shareholders. Arrowhead is a biopharmaceutical company that develops targeted RNAi therapeutics in the United States. Arrowhead Research Corp. (NASDAQ:ARWR) in last trading activity decreased -4.25% to close at $6.76. Company weekly performance is 6.96% while its quarterly performance stands at 2.89%. Arrowhead Research Corp. (NASDAQ:ARWR) is -75.53% away from its 52 week high.
Xilinx, Inc. (Nasdaq:XLNX) announced third quarter fiscal 2015 sales of $594 million, down 2% from the prior quarter and up 1% from the same quarter of the prior fiscal year. Third quarter fiscal 2015 net income was $168 million or $0.62 per share, including a $0.02 per diluted share benefit primarily related to the reinstatement of the R&D tax credit. On last trading day Xilinx Inc. (NASDAQ:XLNX) increased 1.10% to close at $41.51. Its volatility for the week is 2.53% while volatility for the month is 2.02%. XLNX’s sales growth for past 5 years was 5.50% and its EPS growth for past 5 years was 10.80%. Xilinx Inc. (NASDAQ:XLNX) monthly performance is -5.03%.
On January 13, Medivation Inc (NASDAQ:MDVN) is expected to report earnings per share of $2.74 for the current fiscal year, as per consensus of analysts. Medivation Inc (NASDAQ:MDVN) reported last earnings figures on November 06th. The company announced actual earnings per share of $0.96 against the consensus Street estimate of $0.83. This represents a year-on-year increase of earning per share of $1.14 from corresponding quarter of last year. Medivation Inc posted revenue of $200.48 million versus estimate of $182.08 million. Medivation, Inc. (NASDAQ:MDVN) has 1.50% insider ownership while its institutional ownership stands at 95.50%. In last trading activity company’s stock closed at $111.20.
Equities researchers at Jefferies Group hoisted their target price on shares of Ixia (NASDAQ:XXIA) from $9.00 to $10.00 in a research report issued on Tuesday. The firm currently has a “hold” rating on the stock. Jefferies Group’s target price indicates a potential downside of 2.82% from the stock’s previous close. On last trading day Ixia (NASDAQ:XXIA) increased 2.04% to close at $10.50. Its volatility for the week is 5.04% while volatility for the month is 3.52%. XXIA’s sales growth for past 5 years was 21.60% and its EPS growth for past 5 years was 21.30%. Ixia (NASDAQ:XXIA) monthly performance is -1.50%.